Cianna Medical, Inc., a women’s health company, today announced the outcomes of a large, retrospective study demonstrating the safety and efficacy of the SAVI® breast brachytherapy applicator. Researchers reported favorably low recurrence rates, high rates of survival and excellent cosmetic outcomes. SAVI is a strut-based applicator that delivers a form of accelerated partial breast irradiation (APBI) known as breast brachytherapy, a 5-day course of targeted radiation for early-stage breast cancer.